| UHC Commercial Medical & Drug | Facet Joint and Medial Branch Block Injections for Spinal Pain - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | FcRn Blockers (Rystiggo®, Vyvgart®, & Vyvgart Hytrulo®) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | FDA Cleared or Approved Companion Diagnostic Testing - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Gamifant® (Emapalumab-Lzsg) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Gastrointestinal Motility Disorders, Diagnosis and Treatment - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing for Infectious Diarrhea - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Gender Dysphoria Treatment - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Genetic Testing for Cardiac Disease - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Genetic Testing for Hereditary Cancer - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Glaucoma Surgical Treatments - Commercial and Individual Exchange Medical Policy | 2026-01-01 |